Flow cytometry evaluations showing increased CD4 + and CD8 + immune effector cells in the peripheral blood and the growth rate reduction in a secondary untreated tumor suggest that treatment of a primary tumor with IT LSAM-DTX may elicit abscopal effects which reduce the growth rate of distant untreated tumors. The gene discussed is CD8A; the disease is neoplasm.